moclobemide has been researched along with As If Personality in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oosterbaan, DB | 1 |
| van Balkom, AJ | 1 |
| Spinhoven, P | 1 |
| de Meij, TG | 1 |
| van Dyck, R | 1 |
| Versiani, M | 1 |
| Nardi, AE | 1 |
| Mundim, FD | 1 |
| Alves, AB | 1 |
| Liebowitz, MR | 1 |
| Amrein, R | 1 |
2 trials available for moclobemide and As If Personality
| Article | Year |
|---|---|
The influence on treatment gain of comorbid avoidant personality disorder in patients with social phobia.
Topics: Adult; Age of Onset; Cognitive Behavioral Therapy; Comorbidity; Female; Follow-Up Studies; Humans; M | 2002 |
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
Topics: Adult; Benzamides; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; | 1992 |